Clinical Trial Update: Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing tissue penetration of tedizolid in diabetic patients with wound infection and healthy volunteers using in vivo microdialysis; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Wound Infection

Drugs mentioned

• tedizolid (tedizolid)

Snippet

Sponsor: Hartford Hospital | Conditions: Diabetes, Wound Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-01-15